Ursprung des Netzwerks ersten Grades von Koen Huygens
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
33
| Holding Company | Medical Specialties | 33 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Koen Huygens
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Chairman Director/Board Member | |
Arthur D. Little, Inc.
Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
GROUPE BRUXELLES LAMBERT SA | Financial Conglomerates | Director/Board Member Director/Board Member | |
KBC Insurance NV
KBC Insurance NV Multi-Line InsuranceFinance KBC Insurance NV provides risk management and non-life insurance services. The firm offers liability insurance brokerage and industrial accidents, car & fleet, asset protection and debtor management services. The company is headquartered in Brussels, Belgium. | Multi-Line Insurance | Chief Executive Officer Chairman | |
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chairman Corporate Officer/Principal | |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Pharmaceuticals: Generic | Chief Executive Officer Chief Executive Officer | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BNP PARIBAS FORTIS SA | Major Banks | Director/Board Member Director/Board Member | |
The University of Chicago | College/University | Masters Business Admin Masters Business Admin | |
KBC GROUPE NV | Regional Banks | Chief Executive Officer Chairman | |
Instituto de Empresa SL | College/University | Masters Business Admin Graduate Degree | |
Vrije Universiteit Amsterdam | College/University | Doctorate Degree | |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Ghent University | College/University | Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Katholieke Universiteit Leuven | College/University | Graduate Degree Director/Board Member Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
ING Corporate Investments
ING Corporate Investments Investment ManagersFinance ING Corporate Investments focuses on small & medium-sized companies with a turnover of between €5 - €100 million located in Belgium or France. It invest in sectors such as manufacturing, engineering, logistics, distribution, services, information technologies, software, and telecommunications. It provides investments between €2 - €20 million in equity and can invest in convertible notes for MBOs or MBIs, growth, and later-stage venture capital. The fund can act as a lead investor and has an exit horizon of 4 to 6 years. | Investment Managers | Chief Investment Officer | |
Vlerick Leuven Gent Management School | College/University | Director/Board Member Masters Business Admin Masters Business Admin | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Corporate Officer/Principal Director/Board Member | |
Hasselt University | College/University | Doctorate Degree Graduate Degree | |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Chairman Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer General Counsel Director/Board Member | |
PharmaDM NV
PharmaDM NV Packaged SoftwareTechnology Services PharmaDM NV provides drug discovery data analysis solutions. It offers its solutions based on mining integrated chemical, biological, and clinical data. The firm's products include DMax, AlphaDMax, and IDMax. The company was founded by Dr. Luc Dehaspe, Dr. Ross D. King, and Dr. Ashwin Srinivasan in November 2000 and is headquartered in Heverlee, Belgium. | Packaged Software | Director/Board Member Chairman | |
Université Catholique de Louvain | College/University | Graduate Degree Chairman Doctorate Degree Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Founder Private Equity Investor | |
Leids Universitair Medisch Centrum
Leids Universitair Medisch Centrum Hospital/Nursing ManagementHealth Services Leids Universitair Medisch Centrum provides medical research, patient care, training, and education. The firm offers fundamental medical and applied clinical research. The company was founded in 1996 and is headquartered in Leiden, the Netherlands. | Hospital/Nursing Management | Corporate Officer/Principal | |
ACS Biomarker BV
ACS Biomarker BV Medical SpecialtiesHealth Technology ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands. | Medical Specialties | Chief Executive Officer | |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director/Board Member Chairman | |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Universitaire Ziekenhuizen Leuven
Universitaire Ziekenhuizen Leuven Hospital/Nursing ManagementHealth Services Universitaire Ziekenhuizen Leuven provides medical services. It offers abdominal surgery, abdominal transplant surgery and coordination, breast centre, cardiac surgery, dentistry, emergency medicine, endocrinology and haematology. The company was founded in 1080 and is headquartered in Leuven, Belgium. | Hospital/Nursing Management | Director/Board Member Corporate Officer/Principal | |
University of Antwerp | College/University | Undergraduate Degree Undergraduate Degree | |
VCN Biosciences SL
VCN Biosciences SL Miscellaneous Commercial ServicesCommercial Services Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The private company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Gri-Cel SA
Gri-Cel SA Financial ConglomeratesFinance Part of Grifols SA, Gri-Cel SA provides investment services. The private company is based in Barcelona, Spain. The CEO of the Spanish company is Dirk Büscher. | Financial Conglomerates | Chief Executive Officer Chief Operating Officer | |
BePharBel Manufacturing SA
BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology BePharBel Manufacturing SA manufactures and distributes pharmaceutical products. Its products include drugs, tuberculosis and food supplements and cosmetics. The company was founded on March 26, 2012 and is headquartered in Courcelles, Belgium. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
OncoDNA SA
OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Chairman Chief Executive Officer Director/Board Member | |
Fedrus International NV
Fedrus International NV Construction MaterialsNon-Energy Minerals Fedrus International NV operates as a holding company with interests in roofing and façade materials. The company was founded on May 21, 2015 and is headquartered in Puurs, Belgium. | Construction Materials | Director/Board Member | |
Primix Bio Ventures BV | Chief Executive Officer | ||
Tusk Therapeutics NV
Tusk Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Part of Tusk Therapeutics SA, Tusk Therapeutics NV operates as a research organization. The private company is based in Vlaams Brabant, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer | |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Chairman Chief Executive Officer | |
Vaxxilon AG
Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The private company is based in Reinach, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
Gsk Biologicals
Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
Asociacion De Empresas Biotecnologicas
Asociacion De Empresas Biotecnologicas BiotechnologyHealth Technology Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain. | Biotechnology | Director/Board Member | |
BIOSENIC SA | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Genetrix SL
Genetrix SL BiotechnologyHealth Technology Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer | |
BESIX Group NV
BESIX Group NV Engineering & ConstructionIndustrial Services BESIX Group NV engages in the provision of construction and engineering solutions. Its business units include real estate, contracting, and concessions and assets. The real estate business realizes residential and office buildings in prime locations. The Contracting business comprises buildings, marine works, infrastructure, industry, environment; and sports and leisure. The concessions and assets business acquires, invests, operates, and maintains projects. The company was founded in 1909 and is headquartered in Woluwe-Saint-Lambert, Belgium. | Engineering & Construction | Chairman Director/Board Member |
Statistik
International
Belgien | 28 |
Spanien | 9 |
Niederlande | 6 |
Vereinigte Staaten | 3 |
Vereinigtes Königreich | 3 |
Sektoral
Health Technology | 19 |
Consumer Services | 11 |
Finance | 8 |
Commercial Services | 7 |
Health Services | 4 |
Operativ
Director/Board Member | 222 |
Chairman | 74 |
Corporate Officer/Principal | 67 |
Chief Executive Officer | 39 |
Independent Dir/Board Member | 36 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Koenraad Debackere | 48 |
Baron Jean Stéphenne | 36 |
Russell Greig | 31 |
Mounia Chaoui-Roulleau | 27 |
Willy W. Duron | 27 |
Luc Dochez | 26 |
Sven Arne Andréasson | 24 |
Eduardo Bravo Fernández de Araoz | 19 |
Gil Beyen | 18 |
Nico Vandervelpen | 17 |
Joël Jean-Mairet | 17 |
Raf Moons | 15 |
Marie Paule Richard | 15 |
Luc van de Steen | 14 |
June Almenoff | 14 |
- Börse
- Insiders
- Koen Huygens
- Unternehmensverbindungen